Free Trial

Revvity (RVTY) Competitors

Revvity logo
$95.61 +0.71 (+0.75%)
Closing price 07/17/2025 03:59 PM Eastern
Extended Trading
$95.58 -0.03 (-0.03%)
As of 07/17/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RVTY vs. BRKR, TECH, A, DHR, IQV, MTD, TMO, WAT, KEYS, and VLTO

Should you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), Keysight Technologies (KEYS), and Veralto (VLTO).

Revvity vs. Its Competitors

Revvity (NYSE:RVTY) and Bruker (NASDAQ:BRKR) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

In the previous week, Bruker had 4 more articles in the media than Revvity. MarketBeat recorded 9 mentions for Bruker and 5 mentions for Revvity. Bruker's average media sentiment score of 1.06 beat Revvity's score of 0.92 indicating that Bruker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revvity
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bruker
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Revvity pays out 11.9% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

86.7% of Revvity shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 0.7% of Revvity shares are held by company insiders. Comparatively, 27.3% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Revvity has higher earnings, but lower revenue than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revvity$2.76B4.09$270.39M$2.3540.69
Bruker$3.37B1.90$113.10M$0.5281.13

Revvity has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Bruker has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500.

Revvity has a net margin of 10.35% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Revvity10.35% 7.73% 4.72%
Bruker 2.31%19.47%5.95%

Revvity currently has a consensus target price of $123.07, suggesting a potential upside of 28.71%. Bruker has a consensus target price of $52.89, suggesting a potential upside of 25.36%. Given Revvity's stronger consensus rating and higher possible upside, equities analysts plainly believe Revvity is more favorable than Bruker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revvity
0 Sell rating(s)
4 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.73
Bruker
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Revvity and Bruker tied by winning 9 of the 18 factors compared between the two stocks.

Get Revvity News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVTY vs. The Competition

MetricRevvityMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$11.19B$7.08B$5.56B$20.75B
Dividend Yield0.30%2.87%3.80%3.67%
P/E Ratio40.6926.9828.0527.62
Price / Sales4.0936.98437.8959.14
Price / Cash11.1526.7235.8422.13
Price / Book1.529.098.254.66
Net Income$270.39M$233.10M$3.24B$994.58M
7 Day Performance-5.80%0.91%1.45%0.00%
1 Month Performance1.12%2.85%8.04%5.25%
1 Year Performance-12.98%24.57%30.08%10.76%

Revvity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVTY
Revvity
3.5785 of 5 stars
$95.61
+0.8%
$123.07
+28.7%
-15.7%$11.19B$2.76B40.6911,000
BRKR
Bruker
4.9783 of 5 stars
$41.27
-2.8%
$52.89
+28.2%
-34.2%$6.43B$3.37B18.0611,396High Trading Volume
TECH
Bio-Techne
4.8772 of 5 stars
$51.53
-3.0%
$72.00
+39.7%
-31.9%$8.33B$1.16B31.083,100
A
Agilent Technologies
4.732 of 5 stars
$119.21
-1.8%
$140.92
+18.2%
-12.8%$34.48B$6.51B22.4817,900
DHR
Danaher
4.9693 of 5 stars
$199.60
-1.8%
$248.61
+24.6%
-22.5%$145.42B$23.88B27.2763,000Positive News
Upcoming Earnings
IQV
IQVIA
4.9034 of 5 stars
$162.57
-1.0%
$226.32
+39.2%
-29.0%$28.41B$15.41B15.9188,000Upcoming Earnings
MTD
Mettler-Toledo International
4.1541 of 5 stars
$1,188.28
-1.7%
$1,300.36
+9.4%
-12.5%$25.13B$3.87B29.8817,300Positive News
TMO
Thermo Fisher Scientific
4.9925 of 5 stars
$418.76
-2.5%
$604.05
+44.2%
-23.4%$162.07B$42.88B19.60125,000Positive News
Upcoming Earnings
WAT
Waters
4.8144 of 5 stars
$346.35
-1.1%
$388.00
+12.0%
-5.4%$20.84B$2.96B29.417,600Trending News
Analyst Downgrade
KEYS
Keysight Technologies
4.1463 of 5 stars
$162.42
-2.8%
$183.00
+12.7%
+12.0%$28.75B$4.98B38.1315,500Positive News
Analyst Forecast
VLTO
Veralto
2.6097 of 5 stars
$102.69
-1.0%
$110.09
+7.2%
+5.0%$25.72B$5.19B28.5017,000Positive News

Related Companies and Tools


This page (NYSE:RVTY) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners